National Pharmaceutical Pricing Authority

F.NO. 8 (7)/2007/DP/NPPA-Div.II

GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY

NEW DELHI, DATED THE 14/02/2007

ORDER

In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (5) of the Table hereto annexed as the retail price/revised retail price, exclusive of excise duty, sales taxes/VAT and local taxes, if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;

TABLE

Sl. No.	Name of the Formulation	Pack Size	Existing Retail Price (Rs.)	Retail Price without Excise Duty, Sales Tax/VAT and Local Tax, if any (Rs.)
1	Monocomponent Insulin Humalog 100 IU/ml (Insulin Lispro ) Each ml of Insulin Lispro contains 100 IU (3.5mg) Insulin Lispro ( r- DNA origin) as active ingredient, Batch No. A263524, Qty.26770 cartridges	3ml Cartridge	419.25	414.46
2	Monocomponent Insulin Humalog Mix 50 – 100 IU/ml 50% Insulin Lispro and 50% Insulin Lispro Protamine suspension, r – DNA origin Batch No. – A257892 / Qty. 11,225 cartridges	3ml Cartridge	455.35	441.10
3	Monocomponent Insulin Huminsulin Regular 100 IU/ml (Insulin Human Injection) Batch No. – A257871 / Qty. 7500 Cartridge	3ml Cartridge	208.94	221.85
4	Monocomponent Insulin Humalog Pen 100 IU/ml (Insulin Lispro ) Each ml of Insulin Lispro contains : 100 IU (3.5mg) Insulin Lispro ( r- DNA origin) as active ingredient, Batch No. A253908, Qty. 9620 Disposable Pens	3ml Disposable Pen	588.75	581.74
5	Monocomponent Insulin Huminsulin NPH 40 IU/ml (Isophane Insulin Human Suspension) Batch No. – A242057Qty. 17836 vial	10ml Vial	239.29	181.90
6	Monocomponent Insulin Huminsulin Regular 40 IU/ml (Insulin Human Injection) Batch No. – A241504 / Qty. 18174 vial Batch No. – A242252 / Qty. 18342 vial	10ml Vial	239.29	181.90
7	Monocomponent Insulin Huminsulin NPH 100 IU/ml (Isophane Insulin Human Suspension) Batch No. – A241221Qty. 2545 Cartridge	3ml Cartridge	208.94	221.85
8	Monocomponent Insulin Huminsulin NPH 100 IU/ml (Isophane Insulin human Suspension) Batch No. A254774 / Qty. 1620 Cartridges	3ml Cartridge	208.94	221.85
9	Monocomponent Insulin Huminsulin 30/70 100 IU/ml (Isophane Insulin human Suspension) Batch No. A267511 / Qty.43000 Cartridges	3ml Cartridge	208.94	221.85
10	Monocomponent Insulin Huminsulin 30/70 100 IU/ml Vial (30% Neutral Insulin Solution & 70% Isophane Suspension human) Batch No. HIM273 / Qty.7800 Vials	10ml Vial	409.92	405.07
11	Monocomponent Insulin Huminsulin 30/70 100 IU/ml Vial (30% Neutral Insulin Solution & 70% Isophane Suspension human) Batch No. HIM267 / Qty.22080 Vials	10ml Vial	409.92	405.07
12	Monocomponent Insulin Humalog Mix 25 100 IU/ml 25% Insulin Lispro and 75% Insulin Lispro Batch No. A263545 / Qty.22500 Cartridges	3ml Cartridge	445.95	441.01
13	Monocomponent Insulin Humalog 100 IU/ml (Insulin Lispro) Batch No. A261719 / Qty.25700 Cartridges	3ml Cartridge	419.25	414.46
14	Monocomponent Insulin Huminsulin Regular 100 IU/ml (Insulin Human Injection) Batch No. – A257871 / Qty. 5000 Cartridge	3ml Cartridge	208.94	221.85
15	Monocomponent Insulin Humalog 100 IU/ml (Insulin Lispro ) Each ml of Insulin Lispro contains 100 IU (3.5mg) Insulin Lispro ( r- DNA origin) as active ingredient, Batch No. A268235, Qty.7500 cartridges	3ml Cartridge	419.25	415.33

This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of

(a) the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and

(b) the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.

3.(a) Excise Duty, sales taxes/VAT and local taxes, if any, shall be worked out by the company concerned as per the rate applicable and added in the retail price / revised retail price specified in column no (5) of the above table to arrive at the MRP inclusive of all taxes.

(b) The prices fixed/revised is the Maximum Retail Prices (excluding of excise duty, sales taxes/VAT and of local taxes, if any) for the specified pack and packs of similar strength. Companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(c) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.

(A. K. PAL)
Dy. Director

PN/91/2007/F
M/s. Eli-Lilly and Company (I) Pvt. Ltd.

Last Page Updated: 30-10-2018

Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)

ELI-LILLY AND COMPANY (INDIA) PVT.LTD.